VBLT - Vascular Biogenics' (VBLT) CEO Dror Harats on Q1 2021 Results - Earnings Call Transcript

Vascular Biogenics Ltd. (VBLT) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Lee Roth – Investor Relations Dror Harats – Chief Executive Officer Amos Ron – Chief Financial Officer Conference Call Participants Kevin DeGeeter – Oppenheimer Arthur He – H.C. Wainwright Presentation Lee Roth Thank you, Sheryl. Good morning, and thank you joining today’s VBL Therapeutics First Quarter 2021 Financial Results and Corporate Update Conference Call. Leading the call this morning will be Prof. Dror Harats, Chief Executive Officer; and Amos Ron, Chief Financial Officer. A press release with the company’s financial results was issued earlier this morning and as available on the Investor Relations page of the company’s website at vblrx.com. Before I turn call over to management, I’d like to remind everyone that during this conference call forward-looking statements made by management are intended to fall within the Safe Harbor provisions of the

For further details see:

Vascular Biogenics' (VBLT) CEO Dror Harats on Q1 2021 Results - Earnings Call Transcript